A synthetic peptide for use as a blocking control in assays to test for specificity of SLC25 A20 antibody, Alternative Names: SLC25A20 control peptide, SLC25A20 antibody Blocking Peptide, Anti-SLC25A20 Blocking Peptide, Solute Carrier Family 25 Member 20 Blocking Peptide, Carnitine/Acylcarnitine Translocase 20 Blocking Peptide, CAC Blocking Peptide, CACT Blocking Peptide, SLC25A20, SLCA20-25, SLCA20 25, SLCA20-25 Blocking Peptide, SLCA20 25 Blocking Peptide
SLC25A20
Reaktivität: Human
Wirt: Synthetic
BP, WB
Applikationshinweise
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
SLC25A20
(Solute Carrier Family 25 (Carnitine/acylcarnitine Translocase), Member 20 (SLC25A20))
Synonyme
5848 Peptide, BG:DS02740.15 Peptide, CACT Peptide, CG5848 Peptide, Cact Peptide, Dmel\\CG5848 Peptide, cac Peptide, dip6 Peptide, fs(2)ltoRN48 Peptide, n(2)k17003 Peptide, cact Peptide, dif-1 Peptide, SLC25A20 Peptide, DKFZp468F1219 Peptide, zgc:77760 Peptide, PRKAR2A Peptide, CAC Peptide, 1110007P09Rik Peptide, C78826 Peptide, mCAC Peptide, cactus Peptide, solute carrier family 25 (carnitine/acylcarnitine translocase), member 20 Peptide, solute carrier family 25 member 20 Peptide, solute carrier family 25 (carnitine/acylcarnitine translocase), member 20 L homeolog Peptide, solute carrier family 25 (mitochondrial carnitine/acylcarnitine translocase), member 20 Peptide, cact Peptide, slc25a20 Peptide, SLC25A20 Peptide, Slc25a20 Peptide, slc25a20.L Peptide
Hintergrund
SLC25A20 is one of several closely related mitochondrial-membrane carrier proteins that shuttle substrates between cytosol and the intramitochondrial matrix space.It mediates the transport of acylcarnitines into mitochondrial matrix for their oxidation by the mitochondrial fatty acid-oxidation pathway. Mutations in this gene are associated with carnitine-acylcarnitine translocase deficiency, which can cause a variety of pathological conditions such as hypoglycemia, cardiac arrest, hepatomegaly, hepatic dysfunction and muscle weakness, and is usually lethal in new born and infants.